A client with Graves disease is starting methimazole. Complete the discharge-teaching statement.
Drop-down Cloze
Choose your responses, then check the answer.
Explanation
Methimazole should be taken as prescribed and adjusted only with the treating clinician using symptoms and thyroid laboratory follow-up. Fever or a severe sore throat can signal agranulocytosis; the client should stop further doses, seek immediate clinical direction, and obtain a complete blood count before restarting as instructed. Jaundice, dark urine, light-colored stool, pruritus, severe fatigue, or abdominal symptoms can signal liver injury and require prompt evaluation. Routine adherence teaching does not mean ignoring serious adverse-effect cues, and feeling better does not confirm that thyroid hormone control is complete.
Correct Answer Take methimazole exactly as prescribed and keep scheduled thyroid follow-up. For fever or severe sore throat, stop further doses and obtain urgent clinical direction and a CBC before restarting. For jaundice or dark urine, seek prompt evaluation for liver injury.
Why It Fits Symptom improvement can occur before stable biochemical control. Agranulocytosis and liver injury are uncommon but potentially serious adverse effects that depend on early symptom recognition and rapid evaluation.
Clinical Picture The client is stable now, so this is prevention teaching. The nurse links ordinary adherence and laboratory follow-up with explicit stop-and-call warning signs rather than presenting every symptom as an emergency.
Memory Link Take and track; fever or sore throat means stop and count; jaundice means liver evaluation.
NCLEX Rule Medication teaching must include what to do when a rare high-risk adverse effect appears. Do not tell the client to wait for the next routine appointment.
Why the Alternatives Fail Stopping whenever symptoms improve risks recurrent hyperthyroidism. Continuing methimazole through fever or severe pharyngitis delays evaluation for agranulocytosis. Treating jaundice or dark urine as an expected harmless effect can miss liver injury.
Source
1DailyMed Methimazole Prescribing Information
2American Thyroid Association Hyperthyroidism Guideline
3American Thyroid Association Hyperthyroidism Patient Guidance
42026 NCLEX-RN Test Plan
The client is clinically stable and says, ‘When I feel better, I may stop the medicine on my own.’ The nurse reviews adherence, scheduled thyroid follow-up, and uncommon but serious blood and liver warning signs before discharge.
Methimazole — An antithyroid medication that reduces new thyroid-hormone synthesis. The dose is managed with symptoms and laboratory follow-up, and the client should not stop it solely because symptoms improve.
Agranulocytosis — A severe reduction in circulating neutrophils that can occur abruptly with antithyroid drugs. Fever or severe sore throat requires stopping further doses and urgent clinical evaluation with a blood count before restart as directed.
Antithyroid Drug Liver Injury — Potential hepatic injury signaled by findings such as jaundice, dark urine, light-colored stool, pruritus, severe fatigue, or abdominal symptoms that require prompt evaluation.